Medline (FRA:L10) Other Financing: €5,542 Mil (TTM As of Mar. 2026)


FRA:L10 Medline Inc FRA:L10
14 GF Score
Price €32.60
! 3 Warning Signs
View Full Analysis

What is Medline Other Financing?

Medline FRA:L10 +5.16% 14 Other Financing is €5,542 Mil as of Mar. 2026. GuruFocus rates FRA:L10 with a GF Score™ of 14/100. The stock has 3 warning signs investors should review.

Medline's Other Financing for the three months ended in Mar. 2026 was €0 Mil.

Medline's Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 was €5,542 Mil.

Medline Other Financing Historical Data

* Premium members only.

The historical data trend for Medline's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medline Other Financing Chart

Medline Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Other Financing
0.00 0.00 -11.46 -30.74

Medline Quarterly Data
Dec23 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Financing Get a 7-Day Free Trial Premium Member Only 0.00 -262.70 -101.39 5,906.26 0.00
FRA:L10
14GF Score
Medline Inc FRA:L10
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medline Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €5,542 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of €5,542 Mil mean?
Medline (FRA:L10) has a Other Financing of €5,542 Mil as of Mar. 2026. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Medline and its competitors.
Is Medline's Other Financing too high?
Medline's current Other Financing is €5,542 Mil. Overall, Medline has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Medline's Other Financing compare to RMD and WST?
Medline's Other Financing of €5,542 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Medical Devices & Instruments company?
A good Other Financing depends on the Medical Devices & Instruments industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Medline and its competitors. Medline's current Other Financing is €5,542 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medline stock overvalued right now?
Medline (FRA:L10) has a current Other Financing of €5,542 Mil. The current Other Financing is €5,542 Mil. Medline's overall GF Score™ is 14/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For Medline (FRA:L10), the current Other Financing is €5,542 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Medline Business Description

Other Exchanges MDLN:USA
Address 3 Lakes Drive, Northfield, IL, USA, 60093
Medline is the largest provider of medical-surgical products and supply chain solutions in the US. The company generates over 90% of its revenue domestically and serves some of the largest US health systems. Medline offers approximately 190,000 Medline-branded products across more than 250 product families—including front-line care, surgical solutions, and laboratory and diagnostics—as well as roughly 150,000 third-party products sourced from over 1,250 vendors. The company maintains prime vendor relationships with many customers, acting as the primary consolidated logistics partner for their medical-surgical needs. Medline has significant scale, supported by more than 30 manufacturing facilities and a fleet of over 2,000 owned delivery trucks. Medline went public in December 2025.
14GF Score

Get the complete analysis for FRA:L10

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€32.60
Price